REQUEST A DEMO
Total
USD $0.00
Search more companies

Antibiotice SA (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Antibiotice SA Profile Updated: September 27, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Antibiotice SA, was established as a joint stock company in 1990 through the acquisition of the business assets of Antibiotics Iasi. Antibiotice SA is the leading Romanian producer of generic drugs. Portfolio of more than 150 drugs covering a wide range. Company shares are traded on the tier of the Bucharest Stock Exchange since April 16, 1997. In 2002, the shares were transferred Antibiotics SA Iasi AVAS, which owns 53%.

Headquarters
Strada Valea Lupului Nr. 1
IASI; Iasi;

Contact Details: Purchase the Antibiotice SA report to view the information.

Website: http://www.antibiotice.ro

Basic Information
Total Employees:
Purchase the Antibiotice SA report to view the information.
Outstanding Shares:
Purchase the Antibiotice SA report to view the information.
Registered Capital:
Purchase the Antibiotice SA report to view the information.
Financial Auditors:
Purchase the Antibiotice SA report to view the information.
Ratings:
Purchase the Antibiotice SA report to view the information.
Incorporation Date:
February 15, 1991
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
53.0173%
Purchase this report to view the information.
26.5496%
Purchase this report to view the information.
20.4331%
Subsidiaries
Company Performance
Financial values in the chart are available after Antibiotice SA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
52.16%
Total operating revenue
50.08%
Operating profit (EBIT)
31.83%
EBITDA
17.14%
Net Profit (Loss) for the Period
19.8%
Total assets
1.13%
Total equity
5.32%
Operating Profit Margin (ROS)
-1.76%
Net Profit Margin
-2.51%
Return on Equity (ROE)
0.45%
Debt to Equity Ratio
-8.22%
Quick Ratio
-0.02%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?